May 22, 2025 | Advisory board, DOL engagement, HCP engagement, Impetus Digital, KOL Engagement, Pharma, Treatment, Virtual advisory board, advisor engagement, digital advisory board, life sciences, medical affairs, treatment mapping, treatment pathway, treatment profiling
Optimize product strategy! Discover how virtual profiling can accurately map treatment pathways and pinpoint opportunities for your innovations while engaging your advisors in a creative way!
Uncover critical insights into product placement and treatment algorithms. This video explores how to leverage virtual collaboration for comprehensive treatment pathway profiling, considering demographic, clinical, and regulatory factors. Empower your advisors to effectively map treatment sequencing and develop strategies for novel combination therapies.
Treatment Pathway Profiling
For more creative ways to engage your advisors, visit: https://www.impetusdigital.com/2019/11/15/top-10-creative-ways-to-engage-your-advisors/
Learn more about Impetus Digital’s solutions: www.impetusdigital.com
Schedule a consultation: https://meetwithimpetus.com/
Stay connected:
#TreatmentPathways #MedicalAffairs #PharmaStrategy #VirtualCollaboration #KOLEngagement #LifeSciences #ImpetusDigital
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Munther Baara, VP Product Strategy and Innovation at EDETEK, discusses all things clinical trials. Especially, we discuss the current gaps and the impact of COVID-19 on the way Pharma approaches…
Cassie Solomon, CEO of The New Group Consulting, dives into the future of innovation, digital technologies, and systems thinking in healthcare. Among many other things, we discuss how organizations can prepare…
A customer story
Laura Towart, Founder & CEO of My Personal Therapeutics, discusses her company’s approach to precision medicine, the barriers patients with cancer face when trying to access personalized treatments, and how…
Kim Shah, CEO of KnowYourMeds, explores digital health, AI, telemedicine, health literacy, and how to ensure a safe return to work amidst the ongoing COVID-19 pandemic. We also dive into…
Dr. Oscar Segurado, Chief Medical Officer at ASC Therapeutics, dives into advanced gene therapies, gene editing, and personalized medicine. We also explore the many different hats he wears as CMO, consultant,…
John Leombruno, CEO of OkRx, shares how his company is working to improve PSP strategy and operations in Canada. He also discusses the impact of COVID-19 on PSPs, digital transformation, clinical…
Chad Walsh, CEO of Sciteline, dives into virtual trials, including their benefits, barriers, and impact on patient-centricity. Among other things, we will discuss data privacy concerns, the role of digital…
Owen Muir, MD, CIO at Brooklyn Minds, explores the secondary effects of COVID-19 on mental health conditions, along with techniques such as deep Transcranial Magnetic Stimulation (dTMS), Mentalization-Based Treatment (MBT), and…
COVID-19 has impacted every aspect of our lives, from the way we shop for groceries to the way we conduct work and interact with healthcare providers and our families.
